Using WHO (2024) anemia guidelines, the overall prevalence of anemia in the study population was 79.3%, with only 20.7% categorized as having normal Hb levels and found similar results even with NFHS-5 guidelines which were 20.72% of the whole population as not anemic. Here, GSTM1 is linked to anemia.